PROJECT WILL STUDY THE ABILITY TO IMAGE A KEY REGULATORY SWITCH IN GLIOBLASTOMA METABOLISM BY THE USE OF PET IMAGING. A NEW PET TRACER TARGETING PKM2 WILL BE USED TO IMAGE THE EARLIEST CHANGES IN RESPONSE TO TREATMENT IN ORDER TO HELP IMPROVE GBM PATIENT MANAGEMENT.

PI: Sanjiv Sam Gambhir M.D., Ph.D.
Chair, Department of Radiology
Director, Molecular Imaging Program at Stanford
Director, Canary Center at Stanford for Cancer Early Detection
Stanford University School of Medicine

Close Menu